Population pharmacokinetic/pharmacogenetic modeling and design of a bayesian estimator for the therapeutic drug monitoring of tacrolimus in lung transplantation

被引：0
|
作者：
Monchaud, C. [1 ]
De Winter, B. [1 ]
Estenne, M. [1 ]
Reynaud-Gaubert, M. [1 ]
Pison, C. [1 ]
Stern, M. [1 ]
Kessler, R. [1 ]
Guillemain, R. [1 ]
Marquet, P. [1 ]
Rousseau, A. [1 ]
机构：
[1] Univ Limoges, INSERM, UMR S850, CHU Limoges, F-87065 Limoges, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
273
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [31] Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data
    Umpierrez, Martin
    Guevara, Natalia
    Ibarra, Manuel
    Fagiolino, Pietro
    Vazquez, Marta
    Maldonado, Cecilia
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [32] Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations
    Monteiro, Joaquim F.
    Hahn, Siomara R.
    Goncalves, Jorge
    Fresco, Paula
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2018, 6 (04):
  • [33] A population pharmacokinetic model to support therapeutic drug monitoring during vedolizumab therapy
    Dreesen, E.
    Verstockt, B.
    Vermeire, S.
    Ferrante, M.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S273 - S274
  • [34] Population pharmacokinetic modeling of oral cyclosporin using NONMEM -: Comparison of absorption pharmacokinetic models and design of a Bayesion estimator
    Rousseau, A
    Léger, F
    Le Meur, Y
    Saint-Marcoux, F
    Paintaud, G
    Buchler, M
    Marquet, P
    THERAPEUTIC DRUG MONITORING, 2004, 26 (01) : 23 - 30
  • [35] In Silico Pharmacokinetic Study of Vancomycin Using PBPK Modeling and Therapeutic Drug Monitoring
    Ferreira, Abigail
    Martins, Helena
    Oliveira, Jose C.
    Lapa, Rui
    Vale, Nuno
    CURRENT DRUG METABOLISM, 2021, 22 (02) : 150 - 162
  • [36] Saliva Sampling in Therapeutic Drug Monitoring and Physiologically Based Pharmacokinetic Modeling: Review
    Almukainzi, May
    DRUG RESEARCH, 2023, 73 (02) : 65 - 69
  • [37] Utility of Population Pharmacokinetic Modeling in the Assessment of Therapeutic Protein-Drug Interactions
    Chow, Andrew T.
    Earp, Justin C.
    Gupta, Manish
    Hanley, William
    Hu, Chuanpu
    Wang, Diane D.
    Zajic, Stefan
    Zhu, Min
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 593 - 601
  • [38] Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation
    Saint-Marcoux, Franck
    Royer, Bernard
    Debord, Jean
    Larosa, Fabrice
    Legrand, Faezeh
    Deconinck, Eric
    Kantelip, Jean-Pierre
    Marquet, Pierre
    CLINICAL PHARMACOKINETICS, 2009, 48 (10) : 667 - 675
  • [39] Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation
    Franck Saint-Marcoux
    Bernard Royer
    Jean Debord
    Fabrice Larosa
    Faezeh Legrand
    Eric Deconinck
    Jean-Pierre Kantelip
    Pierre Marquet
    Clinical Pharmacokinetics, 2009, 48 : 667 - 675
  • [40] Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring
    Merlé, Y
    Mentré, F
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1999, 27 (01): : 85 - 101
12345